Moving Away From a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance

Andrew M Moon^{1

2}, George N Ioannou^{3

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
³ Division of Gastroenterology, University of Washington, Seattle, Washington, USA.
⁴ Division of Gastroenterology, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington, USA.

Editorial

Andrew M Moon et al. Am J Gastroenterol. 2022.

. 2022 Sep 1;117(9):1409-1411.

doi: 10.14309/ajg.0000000000001897. Epub 2022 Jun 24.

Andrew M Moon^{1

2}, George N Ioannou^{3

4}

¹ Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
³ Division of Gastroenterology, University of Washington, Seattle, Washington, USA.
⁴ Division of Gastroenterology, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington, USA.

No abstract available

Comment on

Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.
Wu S, Zhou J, Wu X, Sun Y, Wang B, Kong Y, Zhan S, Jia J, Yang HI, You H. Wu S, et al. Am J Gastroenterol. 2022 Sep 1;117(9):1444-1453. doi: 10.14309/ajg.0000000000001865. Epub 2022 Jun 10. Am J Gastroenterol. 2022. PMID: 35973147
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Innes H, Hamill V, McDonald SA, Hayes PC, Johnson P, Dillon JF, Bishop J, Yeung A, Went A, Barclay ST, Fraser A, Bathgate A, Goldberg DJ, Hutchinson SJ. Innes H, et al. Am J Gastroenterol. 2022 Sep 1;117(9):1454-1461. doi: 10.14309/ajg.0000000000001879. Epub 2022 Jun 24. Am J Gastroenterol. 2022. PMID: 35973177

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49.
1. Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 2020;18:2650–66.
1. Rahib L, Wehner MR, Matrisian LM, et al. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open 2021;4:e214708.
1. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6.
1. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology 2018;68:723–50.